GRANIX (tbo-filgrastim)

**Product type:** Human Prescription Drug

**Active ingredient:** FILGRASTIM

**Strength:** 480 ug/.8mL

**Dosage form:** Injection, Solution

**Route:** Subcutaneous

**Labeler:** Cephalon, LLC

**Marketing category:** BLA (BLA125294)

**Pharmacologic class:** Granulocyte Colony-Stimulating Factor [CS], Increased Myeloid Cell Production [PE], Leukocyte Growth Factor [EPC]